Medreich Fexofenadine

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Fexofenadine hydrochloride 180mg;  

Disponible desde:

Medreich New Zealand Limited

Designación común internacional (DCI):

Fexofenadine hydrochloride 180 mg

Dosis:

180 mg

formulario farmacéutico:

Film coated tablet

Composición:

Active: Fexofenadine hydrochloride 180mg   Excipient: Colloidal silicon dioxide Croscarmellose sodium Hypromellose E-5 Opadry pink 00A94480 Macrogol 6000 Magnesium stearate Mannitol   Silicified microcrystalline cellulose

tipo de receta:

Pharmacy only

Fabricado por:

Virupaksha Organics Pvt. Ltd.

indicaciones terapéuticas:

Relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, PVC/PE/ACLAR or PVC/PVdC/Al - 10 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR or PVC/PVdC/Al - 20 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PE/ACLAR or PVC/PVdC/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Fecha de autorización:

2016-01-22